Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/29/2007US20070275999 Pharmaceutical compositions containing a hypoglycemic agent(s) for improving or treating impaired glucose tolerance, borderline diabetes, insulin resistance or hyperinsulinemia
11/29/2007US20070275998 Deoxynojirimycin and d-arabinitol analogs and methods of using
11/29/2007US20070275997 Perhexiline For Treating Chronic Heart Failure
11/29/2007US20070275996 Use of Statins For The Treatment Of Metabolic Syndrome
11/29/2007US20070275995 Thiobenzimidazole derivatives
11/29/2007US20070275994 Novel Antinfective Compounds
11/29/2007US20070275993 Combinations Of An Anti Emetic Agent And An Enkephalinase Inhibitor
11/29/2007US20070275992 Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers
11/29/2007US20070275991 Drug Delivery From Embolic Agents
11/29/2007US20070275990 Heterocyclic Spiro Compound
11/29/2007US20070275989 Therapeutic Treatment
11/29/2007US20070275988 Transition state structure and inhibitors of thymidine phosphorylases
11/29/2007US20070275987 2-Benzyloxymethyl-3H-pyrido[2,3-d]pyrimidin-4-one; 2-[2-(3-Chloro-phenyl)-ethyl]-3H-pyrido[2,3-d]pyrimidin-4-one; dyslipidemia, atherosclerosis, diabetes, metabolic syndrome
11/29/2007US20070275986 Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
11/29/2007US20070275985 Triazolopyrimidines
11/29/2007US20070275984 Novel Thieno-Pyridine and Thieno-Pyrimidine Derivatives and Their Use as Positive Allosteric Modulators of Mglur2-Receptors
11/29/2007US20070275983 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/29/2007US20070275982 Method
11/29/2007US20070275979 Novel Compounds
11/29/2007US20070275978 Of at Use of an Antagonist Compound of at Least One Receptor Selected From a Group Comprising Beta-Adrenergic Receptors, A at1, 5-Ht5 and Galanin Receptor for Preparing a Pharmaceutical Composition for Treating Rosacea
11/29/2007US20070275977 N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
11/29/2007US20070275975 3-quinuclidinyl amino-substituted biaryl derivatives
11/29/2007US20070275974 Pharmaceutical Composition Of Piperazine Derivatives
11/29/2007US20070275973 Aryl fused azapolycyclic compounds
11/29/2007US20070275972 Pyridopyrazines and the use thereof as kinase inhibitors
11/29/2007US20070275970 Compositions for affecting weight loss
11/29/2007US20070275969 Nanoparticles for oral administration of pharmaceutical agents of low solubility
11/29/2007US20070275968 Substituted Biphenyl Derivative
11/29/2007US20070275966 4'-(2-Oxo-5-(R)-phenyl-oxazolidin-3-ylmethyl) biphenyl-3-carboxylic acid (2-dimethylamino-ethyl)-amide, usedd for the treatment or prevention of neurological and psychiatric disorders
11/29/2007US20070275965 CXCR4 modulators
11/29/2007US20070275964 Cannabinoid receptor ligands and uses thereof
11/29/2007US20070275963 PYRAZOLO[1,5-a]PYRIMIDINES
11/29/2007US20070275962 Heterobicyclic Compounds as Pharmaceutically Active Agents
11/29/2007US20070275961 Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine
11/29/2007US20070275960 Phenyl and pyridyl compounds for inflammation and immune-related uses
11/29/2007US20070275959 Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active Agents
11/29/2007US20070275958 Use of Oxicam Compounds
11/29/2007US20070275957 Use of n-desmethylclozapine to treat human neuropsychiatric disease
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275955 Method of treating tumors
11/29/2007US20070275954 Novel Fused Heterocycles and Uses Thereof
11/29/2007US20070275953 2-Pyridinone Derivatives, Having Hiv Inhibiting Properties
11/29/2007US20070275952 Tie-2 Modulators and Methods of Use
11/29/2007US20070275951 e.g. 1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-oxo-2-[4-(2-piperidin-1-yl-ethyl)-piperidin-1-yl]-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine or cluster headaches, non-insulin-dependent diabetes
11/29/2007US20070275950 2-Phenylpyridine Derivative
11/29/2007US20070275949 Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases
11/29/2007US20070275948 7-[4-(4-Chlorobenzyloxy)Benzenesulfonyl]-8-Methoxy-3-Methyl-2,3,4,5-Tetrahydro-1h-3-Benzazepinium Maleate Or Tosylate As antipyschotics
11/29/2007US20070275947 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
11/29/2007US20070275946 Cytokine Inhibitors
11/29/2007US20070275945 complex of 1,2-benzisothiazolin-3-one and zinc oxide, useful as antimicrobial agents; resistance to being leached from substrate to which they are attached
11/29/2007US20070275944 Antioxidants and methods of their use
11/29/2007US20070275943 Method and Composition for Treatment or Prophylaxis of Amyloidosis Disorders
11/29/2007US20070275942 Compositions and Uses of Et 743 for Treating Cancer
11/29/2007US20070275941 Salt sensitivity and prevention of hypertension with drospirenone
11/29/2007US20070275940 Composition containing Vitamin D and phytoestrogens
11/29/2007US20070275939 Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
11/29/2007US20070275938 1-Alpha, 3-beta, 17-beta-trihydroxy-4 alpha-fluoroandrost-5-ene; cystic fibrosis, neutropenia, rheumatoid arthritis
11/29/2007US20070275937 1-Alpha, 3-beta, 17-beta-trihydroxy-4 alpha-fluoroandrost-5-ene; cystic fibrosis, neutropenia, rheumatoid arthritis
11/29/2007US20070275936 Formulations and Treatment Methods
11/29/2007US20070275935 Estratriene Derivatives
11/29/2007US20070275934 Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
11/29/2007US20070275933 mixture of sustained release oral minocycline hydrochloride (tetracyclin) antibiotic, and fast dissolving carrier (lactose monohydrate), and slow dissolving carrier (hydroxypropylmethylcellulose) at ratio of about 0.3 to 0.5; coating; once-a-day dosing regimen
11/29/2007US20070275932 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
11/29/2007US20070275931 Bisphosphonate compounds and methods
11/29/2007US20070275930 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
11/29/2007US20070275929 Composition and method for controlling the transmission of noroviruses
11/29/2007US20070275928 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
11/29/2007US20070275927 Cosmetic Use of Polysaccharide Compounds Containing Non-Polymer Siloxane Graft(S)
11/29/2007US20070275923 CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
11/29/2007US20070275922 RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS
11/29/2007US20070275921 Oligomeric Compounds That Facilitate Risc Loading
11/29/2007US20070275919 Rna Amidates and Thioamidates for Rnai
11/29/2007US20070275918 Induction of Cellular Senescence by Cdk4 Disruption for Tumor Suppression and Regression
11/29/2007US20070275915 Tmprss2 Regulatory Sequences and Uses Thereof
11/29/2007US20070275914 Therapeutic Compositions
11/29/2007US20070275913 Compositions and their uses directed to hepcidin
11/29/2007US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/29/2007US20070275910 Phosphoramidate Derivatives
11/29/2007US20070275909 Useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels; carbohydrate-containing pyrazolidinone or oxazolidinone derivatives, for example
11/29/2007US20070275908 Methods and Compositions for the Enzymatic Synthesis of Gangliosides
11/29/2007US20070275907 Glucose transport inhibitors and methods of use
11/29/2007US20070275906 Compounds and Compositions as Channel Activating Protease Inhibitors
11/29/2007US20070275905 Salts of trimebutine and n-desmethyl trimebutine
11/29/2007US20070275904 Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same
11/29/2007US20070275903 oligopeptide conjugates; cleavable by trouase such as Thimet oligopeptidase; antitumor agents
11/29/2007US20070275893 Compositions for enhanced epithelial permeation of peptide yy for treating obesity
11/29/2007US20070275887 Method of Inhibiting Secretase Activity
11/29/2007US20070275883 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
11/29/2007US20070275881 Oligosaccharide Compositions and Use Thereof in the Treatment of Infection
11/29/2007US20070275878 No-modified hemoglobins and uses therefor
11/29/2007US20070275877 Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
11/29/2007US20070275876 administering a membrane permeable thiol in the form thiol itself or in the form of said membrane permeable thiol disulfide bonded to protein that metabolizes in vivo to produce membrane permeable thiol, reduces extracellular cystine and is concurrently oxidized to a disulfide; cancer, diabetes, AIDS etc
11/29/2007US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007US20070275436 polypeptide comprising an amino acid sequence having polyene polyketide synthase activity; involved in the biosynthesis of novel polyketides, inhibitors of fungal cell growth and cancer cell growth
11/29/2007US20070275118 Hot Liquid Fiber Product
11/29/2007US20070275108 Life Span Managment
11/29/2007US20070275106 Hydroxylated polymethoxyflavone compositions
11/29/2007US20070275102 Method of affecting sleep and sleep-related behaviors
11/29/2007US20070275099 MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease
1 ... 3481 3482 3483 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 ... 7860